Arteris, Inc.AIPNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank61
5Y CAGR-30.9%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-30.9%/yr
Long-term compound
Percentile
P61
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 4.58% |
| Q3 2025 | 3.92% |
| Q2 2025 | 2.60% |
| Q1 2025 | 2.86% |
| Q4 2024 | -3.28% |
| Q3 2024 | 11.25% |
| Q2 2024 | -1.09% |
| Q1 2024 | 1.61% |
| Q4 2023 | -3.04% |
| Q3 2023 | -9.02% |
| Q2 2023 | 6.20% |
| Q1 2023 | 10.30% |
| Q4 2022 | -6.39% |
| Q3 2022 | 6.28% |
| Q2 2022 | 9.68% |
| Q1 2022 | -7.66% |
| Q4 2021 | 34.58% |
| Q3 2021 | 18.43% |
| Q2 2021 | -1.73% |
| Q1 2021 | 26.26% |
| Q4 2020 | 29.09% |
| Q3 2020 | 2.44% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |